Any adverse events including hepatic and renal toxicity · children with SCD
1 finding from 1 review
Any adverse events including hepatic and renal toxicity · people with SCD
1 finding from 1 review
no estimate extracted
80 participants
Low
Adverse events None of the included studies evaluated adverse events · young people (aged 10 to 18 years old) with harmful sexual behaviour
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events None of the included studies evaluated adverse events · young people (aged 10 to 18 years old) with harmful sexual behaviour
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Rate of discontinuation due to all other adverse events · Women of reproductive age seeking to avoid pregnancy
Intensive counseling showed no clear difference in rate of discontinuation due to all other adverse events compared with usual family planning care (low certainty).
1 finding from 1 review
Serious adverse events (classified by MedDRA) (Range of · infants
IPV‐OPV showed no clear difference in serious adverse events (classified by MedDRA) (Range of compared with OPV (low certainty).
1 finding from 1 review
Serious adverse events at time point closest to 90 days · participants with internal medicine diseases and conditions
It is very uncertain whether short‐stay unit hospitalisation changes serious adverse events at time point closest to 90 days compared with usual care (very low certainty).
1 finding from 1 review
RR 0.95 [0.59, 1.54]
1907 participants
Very low
Adverse events ‐ total participants with adverse events · patients (mainly young male adults) with fractures of the middle third of the clavicle
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Topical diclofenac gel or solution Local adverse events · adults with chronic musculoskeletal pain (osteoarthritis)
1 finding from 1 review
Intraoperative serious, life‐threatening adverse events · patients with tracheostomy
Percutaneous techniques showed no clear difference in intraoperative serious, life‐threatening adverse events compared with surgical techniques (low certainty).
1 finding from 1 review
Adverse events Hypersensitivity reaction to vaccination · Adults and elderly
1 finding from 1 review
Number of women reporting adverse events ‐ not reported · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of women reporting adverse events ‐ not reported · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of women reporting adverse events ‐ not reported · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of women reporting adverse events ‐ not reported · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · patients with axSpA (AS and nr‐axSpA)
Traditional NSAIDs showed no clear difference in withdrawals due to adverse events Due to adverse events compared with placebo (high certainty).
1 finding from 1 review
RR 0.75 [0.46, 1.21]
1165 participants
High
Intervention not reported
Adverse events Participants (n) reported adverse events · patients with treating osteoarthritis
The intervention showed no clear difference in adverse events Participants (n) reported adverse events (moderate certainty).
1 finding from 1 review
Adverse events Participants (n) reported adverse events · patients with treating osteoarthritis
It is very uncertain whether boswellia serrata changes adverse events Participants (n) reported adverse events compared with valdecoxib (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse events Participants (n) reported adverse events · patients with osteoarthritis
The intervention showed no clear difference in adverse events Participants (n) reported adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events Participants (n) reported adverse events · patients with osteoarthritis
The intervention showed no clear difference in adverse events Participants (n) reported adverse events (moderate certainty).
1 finding from 1 review